Sign up to save your podcasts
Or
Share #72 - Mast Cell Disease, the Hematologist & New Treatments on the Horizon
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#72 - Mast Cell Disease, the Hematologist & New Treatments on the Horizon
Why talk to a hematologist about mast cell disease and systemic mastocytosis treatment?
Dr. Douglas Tremblay, a leading hematologist, joins Dr. G and Kortney to discuss the role of a hematologist-oncologist in diagnosing and treating mastocytosis. We discuss bone marrow's vital role in diagnosing and treating systemic mastocytosis.
Dr. Tremblay discusses the latest KIT inhibitors, a promising group of medications, and explains the difference between indolent and advanced systemic mastocytosis. He clarifies how KIT inhibitors work and emphasizes the importance of managing side effects. Finally, Dr. Tremblay provides insights into the future of KIT inhibitor approval and explores the possibility of participating in a clinical trial for Bezulastinib.
What we cover in this episode about treating systemic mastocytosis:
- What is a hematologist looking at with mast cell disease patients?
- Bone marrow biopsy for systemic mastocytosis
- Avapritinib
Resources about mast cell disease:
Dr. Tremblay: https://profiles.mountsinai.org/douglas-a-tremblay
Dr. Tremblay’s email: [email protected]
Mast Cell Disease Overview: https://allergyasthmanetwork.org/health-a-z/mast-cell-diseases/
What is Anaphylaxis? https://allergyasthmanetwork.org/anaphylaxis/
What is Epinephrine? https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/
The Mast Cell Disease Society: https://tmsforacure.org/
Current studies enrolling patients: https://tmsforacure.org/clinical-trials/
View all episodes
By The Itch: Allergies, Asthma & Immunology
4.3
8686 ratings
Why talk to a hematologist about mast cell disease and systemic mastocytosis treatment?
Dr. Douglas Tremblay, a leading hematologist, joins Dr. G and Kortney to discuss the role of a hematologist-oncologist in diagnosing and treating mastocytosis. We discuss bone marrow's vital role in diagnosing and treating systemic mastocytosis.
Dr. Tremblay discusses the latest KIT inhibitors, a promising group of medications, and explains the difference between indolent and advanced systemic mastocytosis. He clarifies how KIT inhibitors work and emphasizes the importance of managing side effects. Finally, Dr. Tremblay provides insights into the future of KIT inhibitor approval and explores the possibility of participating in a clinical trial for Bezulastinib.
What we cover in this episode about treating systemic mastocytosis:
- What is a hematologist looking at with mast cell disease patients?
- Bone marrow biopsy for systemic mastocytosis
- Avapritinib
Resources about mast cell disease:
Dr. Tremblay: https://profiles.mountsinai.org/douglas-a-tremblay
Dr. Tremblay’s email: [email protected]
Mast Cell Disease Overview: https://allergyasthmanetwork.org/health-a-z/mast-cell-diseases/
What is Anaphylaxis? https://allergyasthmanetwork.org/anaphylaxis/
What is Epinephrine? https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/
The Mast Cell Disease Society: https://tmsforacure.org/
Current studies enrolling patients: https://tmsforacure.org/clinical-trials/
More shows like The Itch: Allergies, Asthma, Eczema & Immunology
View all
Real Time with Bill Maher
16,391 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
The Daily
111,917 Listeners
Up First from NPR
56,285 Listeners
Where Should We Begin? with Esther Perel
14,849 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
The Dr. Hyman Show
9,367 Listeners
The Peter Attia Drive
7,967 Listeners
AAAAI Podcast: Conversations from the World of Allergy
47 Listeners
On Purpose with Jay Shetty
27,238 Listeners
AMA Update
100 Listeners
Huberman Lab
28,527 Listeners
ZOE Science & Nutrition
2,039 Listeners
The Mel Robbins Podcast
20,604 Listeners
The Jefferson Fisher Podcast
8,054 Listeners